According to CB Insights, venture investments in A.I. are declining each quarter in 2023, with the number of venture deals reaching a low level not seen since 2017. . . . → Read More: Infographic: A.I. Getting Hype, But Fewer Venture Funds
|
|||||
       |
A company producing tissue samples in the lab, for drug discovery and preclinical research with robotics and artificial intelligence, raised $38 million in seed funding. . . . → Read More: Lab-Grown Tissue Company Gains $38M in Seed Funds 
A company formed earlier this year is developing precision treatments for bacteria resistant to conventional antibiotics, and raising £4.3 million ($US 5.4 million) in seed funds. . . . → Read More: Start-Up Developing Precision Antibiotics for Resistant Bacteria  Comments are closed  Finance, New products  biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, life sciences, pharmaceuticals, physical sciences, U.K., university, venture capital 
A developer of synthetic antibodies for neurodegenerative disorders delivered like gene therapies is raising €129 million ($US 138 million) in its first venture funding round. . . . → Read More: Antibody/Gene Therapy Biotech Gains $138 Million in Early Funds Comments are closed Finance, New products biomedical, biotechnology, entrepreneurs, equity, Europe, genomics, investment, life sciences, pharmaceuticals, venture capital 
Venture funding for digital health start-ups continued heading down in the third quarter of 2023, reaching low levels not seen in almost a decade. . . . → Read More: Infographic – Digital Health Funding Continues Slide Comments are closed Finance biomedical, engineering, entrepreneurs, equity, investment, medical device, software, statistics, venture capital 
A new-business accelerator program, begun earlier this year to advance and commercialize biomedical research discoveries from academic labs, is receiving a $100 million founding grant. . . . → Read More: Life Science Incubator Gains $100M in Start-Up Funds Comments are closed Finance, Joint ventures/collaborations biomedical, biotechnology, entrepreneurs, equity, grant, investment, life sciences, medical device, pharmaceuticals, university, venture capital 
A new company is underway that says it adapts the gene editing technique Crispr to make detecting nucleic acid targets like DNA or RNA faster and simpler. . . . → Read More: Start-Up Adapts Crispr for Molecular Detection, Raises $40M Comments are closed Finance, New products biomedical, biotechnology, chemistry, engineering, entrepreneurs, equity, genomics, investment, life sciences, medical device, nanotechnology, patent, physical sciences, university, venture capital 
Venture investments in U.S. life science and biotechnology start-ups in the third quarter of 2023 rose from the previous two quarters to reach pre-pandemic levels. . . . → Read More: Infographic – Q3 Life Science Venture Funds Tick Up Comments are closed Finance biotechnology, entrepreneurs, equity, investment, life sciences, statistics, venture capital 
An organization funding research on extending the human life span by preventing age-related diseases is founding its first biotechnology company. . . . → Read More: Longevity Science Group Spins-Off Biotech Start-Up 
A developer of treatments for Alzheimer’s disease that seeks to improve the condition of the brain’s support cells is raising £48 million ($US 61 million) in its first venture round. . . . → Read More: Neuro Disease Biotech Gains $61M in Early Funds Comments are closed Finance, New products biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, physical sciences, U.K., university, venture capital |
||||
|
Copyright © 2023 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts